Profile
Hakon Leffler is the founder of Galecto Biotech ApS and Galecto, Inc. which were both founded in 2011.
He is currently a Director at Lundonia Biotech AB and a Professor at the University of Lund.
He was previously a Principal at the University of California, San Francisco.
Hakon Leffler active positions
| Companies | Position | Start |
|---|---|---|
Lundonia Biotech AB
Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Provides academic as well as industrial research and development with diagnostic tools | Director/Board Member | 06/07/2009 |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Hakon Leffler
| Companies | Position | End |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| DAMORA THERAPEUTICS, INC. | Founder | - |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundonia Biotech AB
Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Provides academic as well as industrial research and development with diagnostic tools | Commercial Services |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Stock Market
- Insiders
- Hakon Leffler
















